How do you calculate the CHA₂DS₂-VASc score?

Add one point each for CHF, hypertension, diabetes, vascular disease, age 65–74, and female sex; two points for age ≥75 and for prior stroke/TIA/thromboembolism. Maximum is 9. Example: woman age 77 with diabetes and prior TIA → age ≥75 (+2) + diabetes (+1) + stroke (+2) + female (+1) = 6 points (~9.7% estimated annual stroke risk in Friberg data).

What does CHA₂DS₂-VASc stand for?

Congestive heart failure, Hypertension, Age ≥75 (doubled), Diabetes, Stroke/TIA/thromboembolism (doubled), Vascular disease, Age 65–74, and Sex category (female). It applies to non-valvular atrial fibrillation stroke risk stratification—not heart attack risk.

When are blood thinners recommended by score?

Teaching summary aligned with ESC/AHA patterns: men with score ≥2 and women with score ≥3 — offer oral anticoagulation (DOAC or warfarin) if bleeding risk acceptable. Men with score 1 or women with score 2 — consider individually. Score 0, or score 1 in a woman from sex alone — anticoagulation usually not indicated for stroke prevention from the score alone.

What does a CHA₂DS₂-VASc score of 3 mean?

Three points ≈ 3.2% estimated annual stroke risk without anticoagulation (Friberg cohort). For a man, score 3 is above the usual ≥2 threshold for recommending OAC. For a woman, score 3 meets the common ≥3 threshold. Always integrate bleeding risk, adherence, and patient preference.

Does being female automatically mean I need anticoagulation?

No. Female sex adds 1 point as a risk modifier. A woman under 65 with no other factors has score 1 (~0.6%/year) and is generally not anticoagulated for stroke prevention based on score alone. A woman with hypertension, age 70, and female sex has score 3 — different conversation.

How is CHA₂DS₂-VASc different from CHADS₂?

CHADS₂ uses CHF, hypertension, age ≥75 (+1), diabetes, and stroke (+2) — max 6 points. CHA₂DS₂-VASc adds vascular disease, splits age into 65–74 (+1) and ≥75 (+2), and adds female sex (+1). The update improves sensitivity for identifying truly low-risk patients (score 0) and moderate-risk borderline cases.

Are CHADSVASc, CHADS2VASc, and CHA2DS2-VASc the same?

Yes — spelling variants for the same clinical score. Search engines use CHADSVASc calculator, CHA2DS2-VASc score calculator, and CHADVASC interchangeably; the validated components are identical.

What is non-valvular atrial fibrillation?

AFib not due to moderate-to-severe mitral stenosis or a mechanical heart valve. Patients with mechanical valves or significant valvular disease often require anticoagulation regardless of CHA₂DS₂-VASc. This score is for the much larger non-valvular AF population.

What counts as vascular disease?

Prior myocardial infarction, peripheral artery disease, or complex aortic plaque — each counts as +1. Coronary disease without MI may not qualify depending on documentation; use the diagnosis recorded in the chart.

Is aspirin enough instead of a DOAC or warfarin?

Current guidelines do not recommend aspirin alone for stroke prevention in AFib when anticoagulation is indicated — DOACs or warfarin are substantially more effective. Aspirin may still appear in broader cardiovascular plans for other reasons, but not as a substitute for indicated OAC.

Should I use HAS-BLED with this score?

Yes in real practice. CHA₂DS₂-VASc estimates ischemic stroke risk; HAS-BLED estimates major bleeding on anticoagulation. High stroke score does not automatically mean start OAC if bleeding risk is prohibitive — shared decision-making balances both.

Do I recalculate the score over time?

Yes. Turning 65 or 75 changes age points; new hypertension, diabetes, or stroke changes the total. Recalculate at follow-up visits — a score of 0 at age 60 may become 2 at age 76 without other new diagnoses.

theCalcs

Get Custom Solution

Loading calculators...

Fetching calculator categories and tools for this section.

Go to Calculators Browse Calculators

Loading the page...

Preparing tools and content for you. This usually takes a second.

Go Home Browse Calculators

Score	Annual stroke risk	Teaching note
0	0.2%	Very low risk
1	0.6%	Low; context-dependent (sex in women)
2	2.2%	Moderate to moderate-high
3	3.2%	Moderate to moderate-high
4	4.8%	High — OAC often discussed
5	7.2%	High — OAC often discussed
6	9.7%	High — OAC often discussed
7	11.2%	High — OAC often discussed
8	10.8%	High — OAC often discussed
9	12.2%	High — OAC often discussed

Sex	Score	Stroke risk	Typical teaching
Men	0	~0.2%/year	Anticoagulation for stroke prevention generally not indicated from score alone
Men	1	~0.6%/year	Consider OAC after shared decision-making and bleeding-risk review
Men	≥2	≥~2.2%/year	Oral anticoagulation generally recommended if no contraindications
Women	0	~0.2%/year	Same as men — very low risk
Women	1 (sex point only)	~0.6%/year	Female sex alone — usually not sufficient for OAC without other factors
Women	2	~2.2%/year	Borderline — consider OAC individually
Women	≥3	≥~3.2%/year	Oral anticoagulation generally recommended if no contraindications

Feature	CHADS₂	CHA₂DS₂-VASc
Age	≥75 (+1 only)	65–74 (+1) or ≥75 (+2)
Vascular disease	Not included	+1
Female sex	Not included	+1 (risk modifier)
Score range	0–6	0–9
Low-risk identification	Less sensitive	Better at labeling true low risk (score 0)

Score	Annual stroke risk	Teaching note
0	0.2%	Very low risk
1	0.6%	Low; context-dependent (sex in women)
2	2.2%	Moderate to moderate-high
3	3.2%	Moderate to moderate-high
4	4.8%	High — OAC often discussed
5	7.2%	High — OAC often discussed
6	9.7%	High — OAC often discussed
7	11.2%	High — OAC often discussed
8	10.8%	High — OAC often discussed
9	12.2%	High — OAC often discussed

Sex	Score	Stroke risk	Typical teaching
Men	0	~0.2%/year	Anticoagulation for stroke prevention generally not indicated from score alone
Men	1	~0.6%/year	Consider OAC after shared decision-making and bleeding-risk review
Men	≥2	≥~2.2%/year	Oral anticoagulation generally recommended if no contraindications
Women	0	~0.2%/year	Same as men — very low risk
Women	1 (sex point only)	~0.6%/year	Female sex alone — usually not sufficient for OAC without other factors
Women	2	~2.2%/year	Borderline — consider OAC individually
Women	≥3	≥~3.2%/year	Oral anticoagulation generally recommended if no contraindications

Loading calculators...

Loading the page...

CHA₂DS₂-VASc Calculator

Low risk

Example scores (this model)

Score components

Score vs estimated annual stroke risk (Friberg)

Anticoagulation teaching thresholds (overview)

CHA₂DS₂-VASc vs CHADS₂

References

Frequently Asked Questions

Share this calculator

Related Calculators

Loading calculators...

CHA₂DS₂-VASc Calculator

Low risk

Example scores (this model)

Score components

Score vs estimated annual stroke risk (Friberg)

Anticoagulation teaching thresholds (overview)

CHA₂DS₂-VASc vs CHADS₂

References

Frequently Asked Questions

Share this calculator

Related Calculators

Letter	Risk factor	Points
C	Congestive heart failure / LV dysfunction	+1
H	Hypertension (treated or >140/90)	+1
A₂	Age ≥75 years	+2
D	Diabetes mellitus	+1
S₂	Prior stroke, TIA, or thromboembolism	+2
V	Vascular disease (MI, PAD, aortic plaque)	+1
A	Age 65–74 years (mutually exclusive with A₂)	+1
Sc	Sex category — female	+1